Task Applied Science

Institution (Healthcare)

Homepage ROR

Also Known As

Task Applied Science

247

Publications

14.2K

Citations

Authors

Concepts

About

Task Applied Science is a healthcare institution in Cape Town, South Africa known for medicine, tuberculosis, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	36	3.3K
2	Health Sciences	6	12	794
3	Engineering	2	2	100
4	Public Health	1	1	35
5	Biomedical Engineering	1	1	17

Task Applied Science

247

Publications

14.2K

Citations

Page 1

	Year	Citations
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane, New England Journal of Medicine	2020	962
Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis Dereck Tait, Mark Hatherill, Olivier Van Der Meeren, New England Journal of Medicine	2019	561
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial Andreas H. Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier, The Lancet AntibioticsMedicineRandomised Trial14-Day Bactericidal ActivityAntibacterial Agent	2012	428
Phase 2b Controlled Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba, New England Journal of Medicine	2018	392
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis Martin J. Boeree, Andreas H. Diacon, Rodney Dawson, American Journal of Respiratory and Critical Care Medicine	2015	310
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt, The Lancet Pulmonary TuberculosisPhase 2BTuberculosis PreventionPharmacologyTuberculosis	2015	248
Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline Andreas H. Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier, American Journal of Respiratory and Critical Care Medicine	2015	200
Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients Andreas H. Diacon, Rodney Dawson, M. Hanekom, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionBactericidal ActivityPharmacotherapyAntimicrobial ChemotherapyDrug Resistance	2010	175
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial Florian von Groote-Bidlingmaier, R. F. Patientia, Epifanio Sánchez, The Lancet Respiratory Medicine	2019	161
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial Conor Tweed, Rodney Dawson, Divan A. Burger, The Lancet Respiratory Medicine	2019	143

Page 1